ReviewExpert review of molecular diagnostics2016

Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.

Ravi SalgiaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.